The Hormel Institute Buys IBM Supercomputer As it Expands Role, Scope of Research
The Hormel Institute, a medical research unit of the University of Minnesota, and IBM (NYSE: IBM) today announced the Institute will become the first research laboratory in the state to employ the world’s most powerful supercomputer design, the IBM Blue Gene.
The Institute’s acquisition of a Blue Gene supercomputer is part of a multi-year expansion for the facility. The expansion and the new computer will allow the Institute – recognized worldwide for its leading-edge cancer research -- to triple the amount of projects it undertakes.
Hormel Institute - Blue Gene photo
Dr. Zigang Dong, M.D., Dr. P.H., executive director of The Hormel Institute and Mike Good, Blue Gene program manager for IBM in Minnesota collaborate to install the first Blue Gene supercomputer in the state of Minnesota at The Hormel Institute, a medical research unit of the University of Minnesota, in Austin, Minn.
‘‘Blue Gene will allow The Hormel Institute to accelerate cancer research and advance the field of research technology,” said Dr. Zigang Dong, M.D., Dr. P.H., executive director of The Hormel Institute. “The expansion of space and talent, combined with providing the most cutting edge technology available in the world, will propel The Hormel Institute to the next level of scientific achievement.”
The Hormel Institute Expansion Project – which includes a new state-of-the-art science lab building and space for 100 new researchers -- is planned to be completed this summer. The grand opening is scheduled October 3 followed by a three-day World Cancer Research Conference, with 200 scientists from around the world expected to participate. The expansion was made possible by support from The Hormel Foundation and Hormel Foods Corporation, along with the City of Austin and Mower County and community support.
Blue Gene -- a Powerful New Partner
The institute’s acquisition of Blue Gene/L – used by 20 of the world’s leading research bodies including Harvard and Princeton Universities and Sweden’s Karolinska Institute – reflects a growing collaboration with IBM.
“Information technology will play a lead role in the 21st century in understanding complex and deadly diseases like cancer. IBM is working with leading scientists to battle this deadly disease. The Hormel Institute is one of those targeted institutions,” said Mike Good, Blue Gene program manager for IBM in Minnesota.
Blue Gene/L, the world’s most powerful supercomputing design, is a modular platform, composed of refrigerator-sized “racks.” The Hormel Institute plans to install one rack of Blue Gene/L, containing 2,048 IBM PowerPC processors and running at 5.6 trillion operations per second, about 300 times faster than a home PC. One person, working non-stop on a calculator, would need 177,000 years to perform the number of calculations that a single rack of Blue Gene/L can do in one second. The PowerPC processors in a single Blue Gene/L rack contain about 95 billion transistors.
Since 2004, the Blue Gene/L platform has led the Top500 list of the world’s most powerful supercomputers (www.top500.org). The Blue Gene family also ranks as the world’s most energy-efficient supercomputer platform. (www.green500.org).
Cancer is the leading cause of death in those under 80 in the United States with approximately 580,000 cancer-related deaths occurring each year, according to the American Cancer Society.
The Hormel Institute comprises a group of highly successful medical scientists who focus on the basic molecular mechanisms of cancer in order to use their findings for the development of new anti-cancer agents.
Video Available: Still images and broadcast-quality video are available for download by registered journalists at http://www.thenewsmarket.com/ibm. The video includes b-roll of The Hormel Institute and interview clips with both IBMers and Hormel researchers.
Note to Bloggers: Images and video are available for download by registered bloggers at www.thenewsmarket.com/videocafe
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.